- Screening
- Baseline
- RQLQ
- After 2nd of the treatment
- At the end of the treatment
- Follow-up week 8
- Follow-up week 12(After 8 weeks of the treatment)
- Follow-up 16 week(After 12 weeks of the treatment)
- Management system of participants
- Speciman management system
- Data management system
- ADR/ADE management system
- Madicine management system
- Instruments management system
- Research team
- Design, Methods
|
women of childbearing age using contraceptives | 是 |
|
no limitations regarding gender or ethnicity | 男性 |
|
patients diagnosed with the disease for at least 1 year, which affected sleep quality during the onset period， | 是 |
|
moderate-to-severe PAR patients aged between 18 to 65 years, and testing positive with a skin prick test for house dust mite (ALK reagent), according to Allergic Rhinitis and its Impact on Asthma (ARIA,2008) | 是 |
|
patients unable to comply with follow-up requests |
|
|
patients with cerebrovascular, lung, liver, kidney or cardiovascular diseases |
|
|
patients with irregular lifestyle |
|
|
long-term users of corticosteroids or immunosuppressive agents |
|
|
patients with nasal polyps, sinusitis, or obvious deviated nasal septum |
|
|
pregnant or breastfeeding women |
|
|
patients aged younger than 18 or older than 65 |
|
|
Nasal Itch |
|
|
Rhinorrhoea |
|
|
nasal obstruction |
|
|
|
|
Sneezing |
|
|
nasal obstruction |
|
|
Rhinorrhoea |
|
|
Sneezing |
|
|
Nasal Itch |
|
|
Non-nasal/eye |
|
|
Emotional function |
|
|
Behavior |
|
|
Sleep |
|
|
Sleep |
|
|
Non-nasal/eye |
|
|
Behavior |
|
|
Emotional function |
|
|
|
|
Sleep |
|
|
Emotional function |
|